Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 12, 2010, Pages 2030-2036

  Silver, Kristopher ^a   Leloup, Ludovic ^a   Freeman, Lisa C ^b   Wells, Alan ^b   Lillich, James D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain activity; Cell migration; Intestinal epithelial cell; NSAIDs; Wound healing

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CALPAIN; CALPAIN 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GASTROINTESTINAL TOXICITY; IN VITRO STUDY; INHIBITION KINETICS; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WOUND HEALING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALPAIN; CELL MEMBRANE; CELL MOVEMENT; HUMANS; INDOMETHACIN; NITROBENZENES; PYRAZOLES; SULFONAMIDES;

EID: 78149284337     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.09.007     Document Type: Article

References (40)

1. Arthur J.S.C., Crawford C. Investigation of the interaction of m-calpain with phospholipids: calpain-phospholipid interactions. Acta Biochem Biophys 1996, 1293:201-206.
2. Ashton M., Hanson P.J. Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea pig gastric mucous cells: inhibition of basal apoptosis by diclofenac. Br J Pharmacol 2002, 135:407-416.
3. Banik N.L., Matzelle D., Terry E., Gantt-Wilford G., Hogan E.L. Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin. Neurochem Res 2000, 25:1509-1515.
4. Beer-Stolz D., Jacobson B.S. Examination of transcellular membrane protein polarity of bovine aortic endothelial cells in vitro using the cationic colloidal silica microbead membrane-isolation procedure. J Cell Sci 1992, 103:39-51.
5. Benyamin Y. The structural basis of calpain behavior. FEBS J 2006, 273:3413-3414.
6. Chaney L.K., Jacobson B.S. Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J Biol Chem 1983, 258:10062-10072.
7. Chou J., Beer-Stolz D., Burke N.A., Watkins S.C., Wells A. Distribution of gelsolin and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced motility. Int J Biochem Cell B 2002, 34:776-790.
8. Delco F., Michetti P., Beglinger C., Fried M., Szucs T.D. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. Digestion 2004, 69:10-19.
9. Dignass A.U. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 2001, 7:68-77.
10. + channels contribute to NSAID-inhibition of intestinal restitution. Biochem Pharmacol 2007, 74:74-85.
11. Fushimi K., Nakashima S., Banno Y., Akaike A., Takigawa M., Shimizu K. Implication of prostaglandin E(2) in TNF alpha-induced release of m-calpain from HCS-2/8 chondrocytes: inhibition of m-calpain release by NSAIDs. Osteoarthr Cartilage 2004, 12:895-903.
12. Glading A., Bodnar R.J., Reynolds I.J., Shiraha H., Satish L., Potter D.A., Wells A., et al. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 2004, 24:2499-2512.
13. Glading A., Chang P., Lauffenburger D.A., Wells A. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 2000, 275:2390-2398.
14. Glading A., Lauffenburger D.A., Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 2002, 12:46-54.
15. Glading A., Uberall F., Keyse S., Lauffenburger D.A., Wells A. Membrane Proximal ERK signaling is required for m-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 2001, 276:23341-23348.
16. Israel L.H., Koea J.B., Stewart I.D., Wright C.L., Frankish P.D. Nonsteroidal anti-inflammatory drug-induced strictures of the colon. Dis Colon Rectum 2001, 44:1362-1364.
17. Karcher L.F., Dill S.G., Anderson W.I., King J.M. Right dorsal colitis. J Vet Intern Med 1990, 4:247-253.
18. Lebart M.-C., Benyamin Y. Calpain involvement in the remodeling of cytoskeletal anchorage complexes. FEBS J 2006, 273:3415-3426.
19. Lichtenberger L.M. Where is the evidence that cyclooxygenase inhibition is the primary cause of neonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol 2001, 61:631-637.
20. Lokuta M.A., Nuzzi P.A., Huttenlocher A. Calpain regulates neutrophil chemotaxis. Proc Nat Acad Sci USA 2003, 100:4006-4011.
21. MacAllister C.G. Effects of toxic doses of phenylbutazone in ponies. Am J Vet Res 1983, 44:2277-2279.
22. MacAllister C.G., Morgan S.J., Borne A.T., Pollet R.A. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993, 202:71-77.
23. Mahmud T., Rafi S.S., Scott D.L., Wrigglesworth J.M., Bjarnason I. Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum 1996, 39:1998-2003.
24. Neiger R. NSAID-induced gastrointestinal adverse effects in dogs - can we avoid them?. J Vet Intern Med 2003, 17:259-261.
25. Oren R., Ligumsky M. Indomethacin-induced colonic ulceration and bleeding. Ann Pharmacother 1994, 28:883-885.
26. Pai R., Szabo I.L., Giap A.Q., Kawanaka H., Tarnawski A.S. Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin, Src, FAK, and tensin signaling. Life Sci 2001, 69:3055-3071.
27. Penney A.G., Malcontenti-Wilson C., O'Brien P.E., Andrews F.J. NSAID-induced delay in gastric ulcer healing is not associated with decreased epithelial cell proliferation in rats. Digest Dis Sci 1995, 40:2684-2693.
28. Perrin B.J., Huttenlocher A. Calpain. Int J Biochem Cell B 2002, 34:722-725.
29. Quaroni A., Wands J., Trelstad R.L., Isselbacher K.J. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biolo 1979, 80:248-265.
30. ATP opener, accelerates restitution of ethanol or indomethacin-induce gastric ulceration in rats independent of polyamines. J Gastroen Hepatol 2001, 16:290-296.
31. Raveendran N.N., Silver K., Freeman L.C., Narvaez D.F., Weng K., Ganta S., et al. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. J Pharmacol Exp Ther 2008, 325:389-399.
32. Rosser B.G., Powers S.P., Gores G.J. Calpain activity increases in hepatocytes following addition of ATP: demonstration by a novel fluorescent approach. J Biol Chem 1993, 268:23593-23600.
33. Satish L., Blair H.C., Glading A., Wells A. Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of μ-Calpain. Mol Cell Biol 2005, 25:1922-1941.
34. Schmassmann A., Tarnawski A.S., Peskar B.M., Varga L., Flogerzi B., Halter F. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol 1995, 268:G276-G285.
35. Shao H., Chou J., Baty C., Burke N.A., Watkins S.C., Beer-Stolz D., et al. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol 2006, 26:5481-5496.
36. Smith S.D., Jia Z., Huynh K.K., Wells A., Elce J.S. Glutamate substitutions at a PKA consensus site are consistent with inactivation of calpain by phosphorylation. FEBS Lett 2003, 542:115-118.
37. Somasundaram S., Sigthorsson G., Simpson R.J., Watts J., Jacob M., Tavares I.A., Roseth A., Price A.B., Bjarnason I., et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibitiion of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharm Ther 2000, 14:639-650.
38. Suzuki K. Modulation of cellular signals by calpain. Ann Proc NY Acad Sci 1992, 674:218-227.
39. Wallace J.L., Vong L. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr Opin Invest Dr 2008, 9:1151-1156.
40. Wolfe M.M., Lichtenstein D.R., Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. New Engl J Med 1999, 341:1397-1399.